|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for HIF1A |
Basic gene info. | Gene symbol | HIF1A |
Gene name | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | |
Synonyms | HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78 | |
Cytomap | UCSC genome browser: 14q23.2 | |
Genomic location | chr14 :62162118-62214977 | |
Type of gene | protein-coding | |
RefGenes | NM_001243084.1, NM_001530.3,NM_181054.2, | |
Ensembl id | ENSG00000100644 | |
Description | ARNT interacting proteinARNT-interacting proteinHIF-1-alphaPAS domain-containing protein 8basic-helix-loop-helix-PAS protein MOP1class E basic helix-loop-helix protein 78hypoxia-inducible factor 1 alpha isoform I.3hypoxia-inducible factor 1, alpha | |
Modification date | 20141222 | |
dbXrefs | MIM : 603348 | |
HGNC : HGNC | ||
Ensembl : ENSG00000100644 | ||
HPRD : 04517 | ||
Vega : OTTHUMG00000140344 | ||
Protein | UniProt: Q16665 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_HIF1A | |
BioGPS: 3091 | ||
Gene Expression Atlas: ENSG00000100644 | ||
The Human Protein Atlas: ENSG00000100644 | ||
Pathway | NCI Pathway Interaction Database: HIF1A | |
KEGG: HIF1A | ||
REACTOME: HIF1A | ||
ConsensusPathDB | ||
Pathway Commons: HIF1A | ||
Metabolism | MetaCyc: HIF1A | |
HUMANCyc: HIF1A | ||
Regulation | Ensembl's Regulation: ENSG00000100644 | |
miRBase: chr14 :62,162,118-62,214,977 | ||
TargetScan: NM_001243084 | ||
cisRED: ENSG00000100644 | ||
Context | iHOP: HIF1A | |
cancer metabolism search in PubMed: HIF1A | ||
UCL Cancer Institute: HIF1A | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of HIF1A in cancer cell metabolism | 1. Maiso P, Huynh D, Moschetta M, Sacco A, Aljawai Y, et al. (2015) Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res 75: 2071-2082. doi: 10.1158/0008-5472.CAN-14-3400. pmid: 4433568. go to article 2. Zhdanov AV, Waters AH, Golubeva AV, Papkovsky DB (2015) Differential contribution of key metabolic substrates and cellular oxygen in HIF signalling. Exp Cell Res 330: 13-28. doi: 10.1016/j.yexcr.2014.10.005. go to article |
Top |
Phenotypic Information for HIF1A(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: HIF1A |
Familial Cancer Database: HIF1A |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
Nat Rev Drug Discovery, 2013, 12: 829, doi: 10.1038/nrd4145 |
Others | |
OMIM | 603348; gene. |
Orphanet | |
Disease | KEGG Disease: HIF1A |
MedGen: HIF1A (Human Medical Genetics with Condition) | |
ClinVar: HIF1A | |
Phenotype | MGI: HIF1A (International Mouse Phenotyping Consortium) |
PhenomicDB: HIF1A |
Mutations for HIF1A |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
ovary | HIF1A | chr14 | 62181961 | 62181981 | HIF1A | chr14 | 62200896 | 62200916 |
pancreas | HIF1A | chr14 | 62205083 | 62205103 | GPHN | chr14 | 67138032 | 67138052 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows HIF1A related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
DB202604 | HIF1A | 1 | 321 | 14 | 62162238 | 62162558 | PRKCH | 321 | 578 | 14 | 61952220 | 61995895 | |
BE545257 | HIF1A | 1 | 81 | 14 | 62207490 | 62207571 | ROMO1 | 80 | 131 | 20 | 34288850 | 34288902 | |
BP330336 | HIF1A | 1 | 403 | 14 | 62162236 | 62187177 | CD63 | 402 | 582 | 12 | 56121079 | 56122794 | |
BE767238 | MXI1 | 2 | 76 | 10 | 112038977 | 112039052 | HIF1A | 69 | 365 | 14 | 62207754 | 62212443 | |
CD656091 | HIF1A | 12 | 312 | 14 | 62212132 | 62212432 | OFD1 | 305 | 825 | X | 13755171 | 13755695 | |
DA461349 | HIF1A | 1 | 474 | 14 | 62162238 | 62187250 | NRP1 | 474 | 576 | 10 | 33467838 | 33467940 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   |   |   |   |   |   | 1 |   | 1 |   |   | 1 |   |   |   | |||
GAIN (# sample) |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   | 1 |   |   | 1 |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=117) | (# total SNVs=14) |
(# total SNVs=3) | (# total SNVs=1) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr14:62194237-62194237 | p.K213Q | 27 |
chr14:62194312-62194312 | p.D238N | 11 |
chr14:62207881-62207881 | p.V690M | 3 |
chr14:62200959-62200959 | p.K328N | 3 |
chr14:62213745-62213745 | p.G808V | 2 |
chr14:62207902-62207902 | p.Q697E | 2 |
chr14:62204876-62204876 | p.E441K | 2 |
chr14:62207327-62207327 | p.K547N | 2 |
chr14:62193462-62193462 | p.S166R | 2 |
chr14:62199167-62199167 | p.E269* | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 | 3 |   | 14 |   |   | 3 |   | 1 |   |   |   | 1 |   |   |   | 6 | 7 |   | 13 |
# mutation | 1 | 3 |   | 14 |   |   | 3 |   | 1 |   |   |   | 1 |   |   |   | 6 | 7 |   | 20 |
nonsynonymous SNV |   | 1 |   | 10 |   |   | 2 |   | 1 |   |   |   | 1 |   |   |   | 4 | 4 |   | 14 |
synonymous SNV | 1 | 2 |   | 4 |   |   | 1 |   |   |   |   |   |   |   |   |   | 2 | 3 |   | 6 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr14:62207881 | p.V714M,HIF1A | 2 |
chr14:62200959 | p.K352K,HIF1A | 2 |
chr14:62211508 | p.S751P,HIF1A | 2 |
chr14:62188359 | p.N713N,HIF1A | 1 |
chr14:62207737 | p.L199L,HIF1A | 1 |
chr14:62213704 | p.K501T,HIF1A | 1 |
chr14:62203609 | p.R269Q,HIF1A | 1 |
chr14:62187113 | p.T514A,HIF1A | 1 |
chr14:62205061 | p.A718T,HIF1A | 1 |
chr14:62188501 | p.L286S,HIF1A | 1 |
Other DBs for Point Mutations |
Copy Number for HIF1A in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for HIF1A |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ACTR2,ACTR3,ASCC3,ATP2A2,BACH1,CCNYL1,CORO1C, ERO1L,EXOC5,FNDC3B,HIF1A,HIVEP2,LIMS1,LOC284441, PANX1,PHACTR2,PPP2R5E,RDX,RNF145,RNF217,SNAPC1 | AHR,BAZ1A,CTBS,DNAJC3,ENAH,FAM91A1,GCH1, HIF1A,LRRC8B,MAGT1,MAPK6,PDE12,SEC23IP,SEC24A, SLC30A7,STARD4,TLR7,TNFRSF10B,UBA6,UGCG,ZFYVE16 | ||||
ALPK2,CLMP,CALU,CD93,CHST15,CHSY1,DOCK4, ELK3,FCGR2A,FPR1,FUT11,GFPT2,HIF1A,HS3ST3B1, IKBIP,KCNJ15,LOX,NRP1,OSMR,SRGN,WISP1 | DNAJB11,DNAJC10,GARS,GTPBP4,HIF1A,HSP90B1,HSPA5, HYOU1,CEMIP,LRP8,MTHFD1L,NAA15,PA2G4P4,PDIA4, RPN2,SRSF1,SLC7A5,SLCO4A1,SSR1,SYNCRIP,YARS |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for HIF1A |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | BindingDB | Q16665; -. |
Chemistry | ChEMBL | CHEMBL2221345; -. |
Organism-specific databases | PharmGKB | PA29283; -. |
Organism-specific databases | CTD | 3091; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB08687 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | experimental | N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE | ||
DB00171 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved; nutraceutical | Adenosine triphosphate | ||
DB00119 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved; nutraceutical | Pyruvic acid | ||
DB00694 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved | Daunorubicin | ||
DB00997 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved; investigational | Doxorubicin | ||
DB00773 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved | Etoposide | ||
DB01204 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved; investigational | Mitoxantrone | ||
DB00155 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved; nutraceutical | L-Citrulline | ||
DB00125 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved; nutraceutical | L-Arginine | ||
DB00435 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | approved | Nitric Oxide |
Top |
Cross referenced IDs for HIF1A |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |